WHO recommends two new drugs to treat COVID-19
The extent to which these medicines, Baricitinib and Sotrovimab, will save lives depends on how widely available and affordable…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
tofacitinib
Pfizer get USFDA nod for XELJANZ (tofacitinib) to treat active polyarticular course juvenile…
Two formulations were approved, a tablet and an oral solution, and are dosed based upon weight
India rejects Pfizer’s patent application for arthritis drug
Quoting a Supreme Court judgement, the order said that the applicant would have to establish the therapeutic enhanced efficacy of…